文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

培养阴性脓毒症临床特征及死亡风险因素分析:基于MIMIC-IV的单中心回顾性队列研究

[Analysis of clinical features and risk factors for mortality in patients with culture-negative sepsis: a single-center retrospective cohort study based on MIMIC-IV].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论培养阴性脓毒症患者较培养阳性者病情更重、住院死亡率更高(25.00% vs 18.53%),90天内既往抗生素使用与死亡风险升高相关。

该研究基于MIMIC-IV v0.4数据库,纳入8587例脓毒症患者,按脓毒症诊断前后24小时内培养结果分为培养阳性组(5483例)和培养阴性组(3104例)。培养阴性组SOFA评分更高、机械通气、肾脏替代治疗和血管加压素使用比例更高、ICU住院时间更长、住院死亡率更高(25.00% vs 18.53%,P<0.01)。多因素调整后培养阴性仍为住院死亡的危险因素(OR=1.441,95%CI 1.273-1.630,P<0.001)。90天内既往抗生素使用与培养阴性脓毒症住院死亡率升高相关(OR=1.683,95%CI 1.328-2.134,P<0.05),中介效应占比7.58%。

要点

  • 培养阴性脓毒症住院死亡率25.00%(776/3104),高于培养阳性组的18.53%(1016/5483),差异有统计学意义(P<0.01)。
  • 多因素调整后,培养阴性脓毒症仍是住院死亡的独立危险因素(OR=1.441,95%CI 1.273-1.630,P<0.001)。
  • 培养阴性组SOFA评分3(2,5)vs 培养阳性组3(2,4),机械通气比例48.61% vs 39.25%,肾脏替代治疗13.69% vs 9.68%,血管加压素使用15.79% vs 13.44%(均P<0.01)。
  • 90天内既往抗生素使用与培养阴性脓毒症住院死亡率升高相关(OR=1.683,95%CI 1.328-2.134,P<0.05),中介效应Z=5.302,P<0.001,占比7.58%。
  • 初始抗生素对培养阴性脓毒症住院死亡率升高无显著影响。

适用人群与场景

  • 从MIMIC-IV v0.4数据库识别的脓毒症患者,最终纳入8587例,其中培养阳性组5483例、培养阴性组3104例。
  • 按脓毒症诊断前24小时至诊断后24小时内的培养结果分组。

研究设计与关键结果

  • 研究类型:单中心回顾性队列研究,基于MIMIC-IV v0.4数据库,纳入8587例脓毒症患者,培养阳性组5483例、培养阴性组3104例。
  • 培养阴性组较培养阳性组:年龄更轻[68(56,79)岁 vs 70(58,81)岁],SOFA评分更高[3(2,5)vs 3(2,4)],机械通气比例更高[48.61%(1509/3104)vs 39.25%(2152/5483)],肾脏替代治疗比例更高[13.69%(425/3104)vs 9.68%(531/5483)],血管加压素使用比例更高[15.79%(490/3104)vs 13.44%(737/5483)],ICU住院时间更长[5(3,10)天 vs 3(2,6)天],住院死亡率更高[25.00%(776/3104)vs 18.53%(1016/5483)],差异均有统计学意义(均P<0.01)。
  • 两组性别、ICU类型、SAPS II评分和CCI评分差异无统计学意义。
  • 多因素调整后,培养阴性脓毒症仍为住院死亡危险因素(OR=1.441,95%CI 1.273-1.630,P<0.001)。
  • 卡方分析和中介分析显示:初始抗生素对培养阴性脓毒症较高的住院死亡率无显著影响;90天内既往抗生素使用与培养阴性脓毒症住院死亡率升高相关(OR=1.683,95%CI 1.328-2.134,P<0.05)。
  • 培养阴性脓毒症在90天内既往抗生素使用与住院死亡之间的中介效应显著(Z=5.302,P<0.001),占比7.58%。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与培养阳性脓毒症相比,培养阴性脓毒症病情更重、预后更差。
  • 作者认为,90天内既往抗生素使用可能与培养阴性脓毒症患者较高的住院死亡率相关,但不能完全解释培养阴性脓毒症的高死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare the characteristics and outcomes of culture-positive sepsis (CPS) with culture-negative sepsis (CNS) patients in order to understand the impact of CNS on prognosis and explore the possible risk factors for mortality.

METHODS: A retrospective cohort study was conducted. Patients with sepsis were identified from the Medical Information Mart for Intensive Care database-IV v0.4 (MIMIC-IV v0.4). Patients were divided into CPS and CNS groups according to the culture results within 24 hours before and after the diagnosis of sepsis. General information, baseline characteristics, and medical operation data between CNS and CPS groups were compared. Logistic regression analysis was used to calculate the relationship between CNS and in-hospital mortality under three regression models. Chi-square analysis and mediation analysis were used to analyze the effect of initial antibiotic and prior antibiotic use within 90 days on the in-hospital mortality of CNS.

RESULTS: A total of 8 587 patients with sepsis were enrolled in the final analysis, including 5 483 patients in the CPS group and 3 104 patients in the CNS group. Compared with the CPS group, the patients in the CNS group were younger [years old: 68 (56, 79) vs. 70 (58, 81)], had higher sequential organ failure assessment (SOFA) score and higher proportion of using mechanical ventilation, renal replacement therapy and vasopressin within 24 hours after intensive care unit (ICU) admission [SOFA score: 3 (2, 5) vs. 3 (2, 4), mechanical ventilation: 48.61% (1 509/3 104) vs. 39.25% (2 152/5 483), renal replacement therapy: 13.69% (425/3 104) vs. 9.68% (531/5 483), vasopressin: 15.79% (490/3 104) vs. 13.44% (737/5 483)], longer length of ICU stay [days: 5 (3, 10) vs. 3 (2, 6)] and higher in-hospital mortality [25.00% (776/3 104) vs. 18.53% (1 016/5 483)], with significant differences (all P < 0.01). However, there was no significant difference in gender, ICU type, simplified acute physiology score II (SAPS II), and Charlson comorbidity index (CCI) score between the two groups. After adjustment for multiple confounding factors, CNS was still a risk factor for in-hospital mortality [odds ratio (OR) = 1.441, 95% confidence interval (95%CI) was 1.273-1.630, P < 0.001]. The results of Chi-square analysis and mediation analysis showed that the initial antibiotic had no significant effect on the higher in-hospital mortality of CNS, while the prior use of antibiotics within 90 days was related to higher in-hospital mortality of CNS (OR = 1.683, 95%CI was 1.328-2.134, P < 0.05). The mediating effect of CNS in prior antibiotic use within 90 days and in-hospital death was significant (Z = 5.302, P < 0.001), accounting for 7.58%.

CONCLUSIONS: Compared with CPS, CNS was more severe and had a worse prognosis. Prior use of antibiotics within 90 days may be related to the higher in-hospital mortality of CNS patients, but it could not fully explain the high mortality of CNS.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Ou Q, Cai G, Zhou Y, et al. [Analysis of clinical features and risk factors for mortality in patients with culture-negative sepsis: a single-center retrospective cohort study based on MIMIC-IV]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34955125. doi:10.3760/cma.j.cn121430-20210525-00780

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。